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The DAF-16 transcription factor controls aging in C.
elegans as part of an insulin-like signaling pathway.
Identification of a target of DAF-16 has opened a new
window into the aging process.
Caenorhabditis elegans has recently proved to be a
truly exciting model system for aging, yielding inter-
esting aging and longevity phenotypes for more than
100 genes. Many longevity genes have roles in basic
metabolism, leading to lively discussions about the
roles of metabolism and associated oxidative damage
in aging [1]. Whatever the nature of aging, the process
is clearly controlled by regulatory pathways. An
insulin-related pathway that promotes wild-type aging
progression was identified and characterized in C.
elegans, and insulin-related pathways were recently
shown to control aging of Drosophila and mice [2,3],
suggesting fundamental importance of this type of
signaling in metazoan aging.
Recent work by Ookuma et al. has shed new light
on the insulin-like aging pathway in C. elegans by
identifying a target of DAF-16, the master transcrip-
tional regulator that extends lifespan when the insulin-
related pathway is downregulated [4].
The mechanism by which daf-16 promotes extended
vigor is unknown beyond the presumption that tran-
scriptional target genes perform the relevant functions.
Ookuma et al. decided to identify genes that extend
lifespan by focusing on potential daf-16 targets. About
5% of C. elegans genes have the 8 bp optimal DAF-16
binding site within 1 kb upstream of the start codon.
From these genes, the authors chose about 150 that
had interesting homologies, and focused on F49E11.9,
which they named SCP-like extracellular protein (scl-1)
(see below). The importance of scl-1 in aging was
demonstrated by the fact that dsRNA-mediated inhibi-
tion (RNAi) of this gene suppressed the extension of life
span in a daf-2 mutant (daf-2 is the insulin receptor
homolog upstream of daf-16), while RNAi of scl-1 in
wild-type worms very slightly shortened lifespan. These
aging phenotypes are quite similar to those of a daf-16
mutant [3]. Thus scl-1, like daf-16, has a progeric (rapid
aging) mutant phenotype, suggesting that the wild-type
function of these genes is to extend lifespan, especially
when insulin signaling is compromised. The authors
propose that scl-1 is a target of DAF-16 and essential to
the mechanism of lifespan extension [4].
The characterization of the scl-1(RNAi) phenotype
as progeric was aided by recent descriptions of the
phenotypic progression of aging [6,7]. Identifying
slowly aging mutants is considered to be unambigu-
ous. If the animal lives longer, it must age more slowly.
Conversely, identifying rapidly aging mutants solely
with reference to lifespan is inappropriate, because
the animals may die early for other reasons. In humans,
some syndromes are identified as progeric because of
the striking resemblance of some symptoms to normal
aging. In C. elegans, a variety of phenotypes associ-
ated with aging have been known for some time, for
example the accumulation of lipofuscin and protein
carbonyl [6,7]. However, these changes may be revers-
ible [8], which makes their relationship to aging
ambiguous. Careful description of aging has expanded
the range of potentially relevant aging phenotypes for
study, but these phenotypes, individually or as a
group, must be shown to be uniquely associated with
aging for progeric mutants to be unambiguously iden-
tified. Some new aging-specific phenotypes have
already been used to distinguish between true progeric
mutants and mutants that shorten lifespan but do not
affect aging. A recent screen turned up five genes
whose RNAi phenotypes included short lifespan, but
only one gene had phenotypes associated with rapid
aging [6]. Phenotypic analysis by Ookuma et al. sug-
gests that the scl-1 mutant is indeed progeric [4].
scl-1 may be the first identified direct target of DAF-
16. Some genes are functionally similar to scl-1 and
daf-16 in that loss of the gene product shortens life-
span, overexpression of the gene product lengthens
lifespan, or both. Some, like sir-2.1 (regulator of chro-
matin structure), hsf-1 (relative of heat shock tran-
scription factor), and old-1 (receptor tyrosine kinase)
are regulatory [1,6], while others, like mev-1 (compo-
nent of electron transport chain) may function by sup-
pressing oxidative damage [1]. Of these genes, only
scl-1 has a nearby match to the optimal DAF-16
binding site. Of course, this fact does not lead to the
conclusion that scl-1 is the only direct target of DAF-
16. The old-1 gene, like scl-1, has daf-16-regulated
expression, and like scl-1, this regulation has not been
demonstrated to be direct. 
What does the sequence of SCL-1 tell us about its
function? SCL-1 has an SCP domain, which is found in
over 300 proteins with numerous biological functions.
These proteins typically enter the secretory pathway
and are either released or anchored extracellularly by
a transmembrane domain or a glycosylphosphatidyl-
inositol (GPI) anchor. Given that scl-1 may function in
signaling or stress resistance, the known biological
functions of a few SCP domain proteins may be rele-
vant to scl-1 [4]: plant SCP proteins function in
pathogen response and other stress responses, and
the C. elegans gene lon-1 functions in a TGFβ signal-
ing pathway. Nevertheless, the specific molecular
functions of SCP domain proteins are unknown.
C. elegans, like other animals, has a large group of
SCP domain proteins [9,10]. SCL-1 is a member of a
subfamily of fifteen nematode-specific proteins; that
is, these proteins are more closely related to each
other than to SCP proteins in other phyla [10]. The
subfamily is unique to nematodes, but the gene func-
tions may not be. C. elegans has a ‘fast clock’ in that
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it accumulates changes in coding sequences relatively
rapidly. Consequently, C. elegans proteins and RNAs
with functions similar to those in other animals often
have a relatively highly diverged sequence [11].
Expression data suggest that other members of this
family may, like scl-1, have a function in aging or
stress resistance. scl-1 shows a modest (not statisti-
cally significant) increase in expression during aging
in wild-type animals [12], consistent with the findings
of Ookuma et al. [4]. During aging, six of the fifteen
genes in the SCL-1 subfamily show strong upregula-
tion [10,12], and none are downregulated. Thus, many
SCL-1 subfamily genes are relatively highly expressed
in aging animals. None of the SCP domain proteins
outside the SCL-1 subfamily appear to be upregulated
in aging animals.
SCL-1 subfamily genes are also highly expressed in
dauer larvae [10,13]. The dauer state is a form of dia-
pause, and is relevant to adult aging because dauers
are non-aging, and many mutations that affect aging
also affect regulation of the dauer state. In addition,
many genes that exhibit regulated expression during
aging also show expression changes in accordance
with the dauer state. The scl-1 gene shows 5-fold
upregulation as worms begin dauer morphogenesis
and 4- to 7-fold downregulation during exit from the
dauer diapause; in this respect, scl-1 is one of many
genes implicated in both aging and dauer development.
Many SCL-1 subfamily genes are also highly expressed
in dauers. During early stages of dauer entry, scl-1 is
the only SCP domain gene that shows strong upregu-
lation. However, during dauer exit, of ten SCL-1 sub-
family genes with good microarray data, six show
strong downregulation. Thus, most genes in the SCL-1
subfamily show relatively high expression in dauers, but
other than scl-1, most do not show strong upregulation
at the beginning of dauer morphogenesis. Presumably
these genes are induced later in the dauer formation
process. In contrast, SCP domain genes outside the
SCL-1 subfamily do not show a strong tendency to be
highly expressed in dauers; two show downregulation
and five show very strong upregulation in dauer exit.
Thus, strong expression in dauers is mostly limited to
the SCL-1 subfamily of proteins in C. elegans.
The predicted secretion of SCL-1 suggests a role in
signaling, and thus SCL-1 potentially provides a tool
for dissecting the role of signaling in aging. Evidence
for hormonal control of aging has been found in
worms, flies and mammals [2]; but the meaning of
these observations has not necessarily been clear. For
example, in mice, defects in growth hormone signal-
ing increase lifespan, but this effect may be a far-
removed pleiotropy stemming from the many effects
of growth hormone on development. This caveat is
true to some degree in all systems.
The evidence suggesting a direct role for hormone
signaling in aging is most clear in C. elegans. First, the
DAF-2 insulin-like pathway functions to control lifespan
with few observable pleiotropies in adults. Inactivation
of the pathway in adults, even postreproductive adults,
can increase lifespan, and inactivation after the com-
pletion of larval development has the same effect as
inactivation throughout the lifespan [14]. This result,
combined with the demonstration that the pathway
acts in the nervous system to influence lifespan [15],
strongly suggests that signaling from the nervous
system directly controls aging. The actual deterioration
associated with aging in C. elegans is seen almost
exclusively outside of the nervous system [6,7], thus
insulin signaling within the nervous system is likely to
act through an unidentified hormone to control the
aging of other tissues. The conserved function of the
insulin pathway in aging suggests that downstream
hormonal cues will be similar, and thus suggests that
the pathway will also function in adult flies and
mammals to control hormones that control aging. 
Other forms of signaling regulate aging in C. elegans,
and these signals act in concert with the insulin
pathway to control development. For example, loss of
germline cells extends lifespan, indicating that a
germline-dependent signal shortens lifespan [16], while
a second signal, from the somatic gonad, extends
lifespan [17]. The extension of lifespan in germline-
ablated animals requires daf-16 function, and germline
ablation leads to the relocalization of DAF-16 to the
nucleus [5]. Thus the germline signal may act to down-
regulate DAF-16 by controlling its activity. However,
germline ablation further extends the lifespan of daf-2
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Figure 1. Model for SCL-1 function in
signaling.
Shown is a schematic view of insulin sig-
naling. The ligand or ligands are shown
originating from a sensory neuron because
many of the insulin genes are expressed in
sensory neurons [19], and sensory input is
known to modulate daf-2 regulated events
[1,5]. However, other sources are possible.
daf-2 functions to regulate aging in the
nervous system and is placed in a secre-
tory neuron because DAF-2 is thought to
regulate a hormonal cue. scl-1 may be
directly regulated by DAF-16, as shown, but
the data are currently ambiguous. SCL-1
and other SCP domain proteins are shown
in the figure as potentially involved in the
hormonal signal from the secretory neuron
or in events further downstream because
we do not yet understand the molecular
function of this family of molecules.
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mutants, suggesting that the effect of germline cells on
aging is not entirely mediated by the insulin-related
pathway. As with insulin signaling in the nervous
system, the germline signal functions in adults to reg-
ulate lifespan, although larval signaling may also be
important [16]. The significance of gonad signaling for
aging in other phyla is uncertain. In some nematode
species, loss of the germline does not affect lifespan
[18]. Finally, sensory input affects lifespan as well;
mutants with defects in chemosensory neurons have
extended lifespans [1].
What is the role of SCL-1 and SCL-1 subfamily pro-
teins in aging? Because the molecular function of SCP
domain proteins is unknown, one must consider the
possibility that SCL-1 plays no role in signaling. SCL-
1 might act in the extracellular space or in an
organelle to protect animals from damage that causes
aging. However, this possibility must be reconciled
with the fact that SCP domain proteins function in
many biological processes that involve signaling. If
SCP proteins have a biochemical role that is protec-
tive, that same biochemical role would very likely have
additional consequences. Examples of a dual role for
protective proteins are known. Many cytochrome
p450s, glutathione S-transferases and UDP-glu-
curonosyltransferases detoxify hydrophobic toxins by
chemical modification. However, other proteins in
these families regulate signaling by modifying signal-
ing molecules such as steroids and eicosanoids.
Where might SCL-1 act in signaling? Expression of
scl-1 is regulated by daf-16, which suggests a role
downstream of the insulin pathway. Because gonadal
and sensory signaling act primarily upstream of daf-16,
SCL-1 would logically be placed downstream of these
types of signaling as well. This placement suggests a
role for SCL-1 in the unidentified daf-16-dependent
signaling pathway that allows the nervous system to
regulate aging of other tissues (Figure 1). However,
other roles are possible. For example, SCL-1 could
function in gonadal signaling, which is upstream of
daf-16, but might also be subject to feedback regula-
tion by DAF-16. One place SCL-1 is not likely to func-
tion is in insulin signaling to the DAF-2 receptor,
because RNAi of scl-1 suppresses a daf-2 mutant. As
to the biochemical role of SCL-1, virtually anything is
possible. Functions postulated for SCP domain pro-
teins include ligand functions, protease inhibition, cell
adhesion, and unspecified enzymatic activities.
The Ookuma et al. paper will probably be the first
drop in a deluge. With the microarray studies and sys-
tematic RNAi screens being performed in C. elegans,
many genes will be identified as targets of DAF-16, as
regulators of aging, or both. A couple of hours spent
playing with databases allowed the identification of
the SCL-1 subfamily as a group of SCP proteins with
related sequence and expression, and therefore
potentially related functions in aging. Understanding
the mechanism by which these genes, especially
genes with mysterious biochemical functions, affect
aging will be a challenge to occupy aging researchers
for the foreseeable future. Clearly, in the case of SCL-
1 and other SCP proteins, identifying a biochemical
function is a key. Perhaps in silico study of newly
identified DAF-16 targets and aging genes will
suggest a protein target that SCL-1 binds, or bio-
chemical work will identify a partner. In any event, we
may be starting work on the most challenging, and
most interesting, part of the puzzle.
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